Controlled trial of N-acetylcysteine for patients with probable Alzheimer’s disease

Clinical diagnosis of Alzheimer's disease: Report of the NINCDS‐ADRDA Work Group* under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease

McKhann, G., Drachman, D., Folstein, M., Katzman, R., Price, D., & Stadlan, E. M. (1984) · Neurology · doi:10.1212/wnl.34.7.939 · Cited by 27,915

Assessment of Older People: Self-Maintaining and Instrumental Activities of Daily Living

Lawton, M. P., & Brody, E. M. (1969) · The Gerontologist · doi:10.1093/geront/9.3_part_1.179 · Cited by 18,540

Assessing Self‐maintenance: Activities of Daily Living, Mobility, and Instrumental Activities of Daily Living

Katz, S. (1983) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.1983.tb03391.x · Cited by 2,734

A Controlled Trial of Selegiline, Alpha-Tocopherol, or Both as Treatment for Alzheimer's Disease

Sano, M., Ernesto, C., Thomas, R. G., Klauber, M. R., Schafer, K., Grundman, M., Woodbury, P., Growdon, J., Cotman, C. W., Pfeiffer, E., et al. (1997) · New England Journal of Medicine · doi:10.1056/nejm199704243361704 · Cited by 2,380

Excess brain protein oxidation and enzyme dysfunction in normal aging and in Alzheimer disease.

Smith, C. D., Carney, J. M., Starke-Reed, P. E., Oliver, C. N., Stadtman, E. R., Floyd, R. A., & Markesbery, W. R. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.23.10540 · Cited by 1,296

Oxidative damage to mitochondrial DNA is increased in Alzheimer’s disease

Mecocci, P., MacGarvey, U., & Beal, M. F. (1994) · Annals of Neurology · doi:10.1002/ana.410360510 · Cited by 1,037

An Assessment of Oxidative Damage to Proteins, Lipids, and DNA in Brain from Patients with Alzheimer's Disease

Lyras, L., Cairns, N. J., Jenner, A., Jenner, P., & Halliwell, B. (1997) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1997.68052061.x · Cited by 531

Autopsy Samples of Alzheimer's Cortex Show Increased Peroxidation In Vitro

Subbarao, K. V., Richardson, J. S., & Ang, L. C. (1990) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1990.tb08858.x · Cited by 463

The Role of Oxidative Stress in Alzheimer Disease

Markesbery, W. R. (1999) · Archives of Neurology · doi:10.1001/archneur.56.12.1449 · Cited by 312

N-acetyl-l-cysteine

de Vries, N., & Flora, S. D. (1993) · Journal of Cellular Biochemistry · doi:10.1002/jcb.240531040 · Cited by 273

Perioperative N-acetylcysteine: evidence and indications

Wilson, P. R., Bridges, K. H., Scofield, M. D., & Wilson, S. H. (2024) · Pain Management · doi:10.1080/17581869.2024.2388504 · Cited by 3

Cognitive Enhancers and Treatments for Alzheimer’s Disease

Devanand, D. P., & Fremont, R. (2024) · Springer eBooks · doi:10.1007/978-3-030-51366-5_139 · Cited by 3

N‐Acetylcysteine and Dementia Risk in Elderly Patients

Sun, M., Lu, Z., Chen, W., Lv, S., Fu, N., Yang, Y., Wang, Y., Miao, M., Wu, S., & Zhang, J. (2026) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.70212 · Cited by 1

N-Acetylcysteine for Reduction of Oxidative Stress/Damage and Prevention of Melanoma

Cassidy, P. B., Leachman, S. A., & Grossman, D. (2012) · Humana Press eBooks · doi:10.1007/978-1-62703-167-7_31 · Cited by 1

Application of N-Acetylcysteine in Neurological Disorders

Shahripour, R., Maleki, A. H. Z., & Alexandrov, A. V. (2018) · Springer eBooks · doi:10.1007/978-981-10-5311-5_11 · Cited by 1

The Role of N-acetyl-L-Cysteine (NAC) as an Adjuvant to Opioid Treatment in Patients with Inadequately Controlled Chronic Neuropathic Pain

Moore, T. B. (2016) · VCU Scholars Compass (Virginia Commonwealth University) · doi:10.25772/p1z0-ja31 · Cited by 1

Complementary and Integrative Psychiatry

Massoumi, L., Gerbarg, P. L., Muskin, P. R., & Naidoo, U. (2019) · American Psychiatric Association Publishing eBooks · doi:10.1176/appi.books.9781615371501.lr37 · Cited by 1

Nefropatía por contraste, un problema común en cardiología intervencionista

Liva, P. D., Agüero, M. A., Moratorio, D. A., Parras, J. I., & Baccaro, J. (2026) · Revista Argentina de Cardiología · doi:10.7775/rac.v72i1.2841 · Cited by 1

Lipoic acid and N-acetyl cysteine protect against mitochondrial-related oxidative stress in fibroblasts from Alzheimer disease patients

Perry, G. L., Moreira, P. I., Harris, P. L. R., Zhu, X., Santos, M. S., Oliveira, C. R., & Smith, M. A. (2007) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/01.jnen.0000268870.37441.52 · Cited by 1

Novel neurotrophic growth factor signaling pathway mediates changes in epigenetics through the redox and methylation influence of EAAT3-mediated cysteine uptake

Hodgson, N. (2012) · doi:10.17760/d20002977 · Cited by 1

Mechanisms of Neuronal Death Induced by Environmental Toxicants in Murine Cortical Culture

Rush, T. (2011)

Effect of proinflammatory activation on the neurosupportive functions of astrocytes

Steele, M. L. (2011)

MULTIFUNCTIONAL POTENTIAL THERAPEUTICS TOWARDS OXIDATIVE STRESS MEDIATED NEURODEGENERATIVE DISORDERS AND MODELS THEREOF

Gururaj Joshi, A. (2006) · UKnowledge (University of Kentucky)

The effects of N-acetylcysteine on behavioral extinction in mice

McDaniel, J. L. (2011)

Evaluation of Photoreactive and Phenothiazine-based HDAC Inhibitors

Madriaga, A. (2014) · Figshare

Nutritional strategies in the management of Alzheimer\'s disease: systematic review and meta-analysis

Fernández, S. S. M. (2016) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/d.89.2016.tde-19102016-165329

Neuroprotection with gluthatione in brain ischemia reperfusion injury

Yabuki, Y., & Fukunaga, K. (2015) · Cerebral Blood Flow and Metabolism (Japanese journal of cerebral blood flow and metabolism) · doi:10.16977/cbfm.26.2_39

Research Priorities for Complementary Medicine in Australia

Bensoussan, A. (2013)

Neurodegenerative Diseases: Parkinson’s and Alzheimer’s Diseases

Ellenstein, A., Prather, C. P., & Коган, М. И. (2017) · Oxford University Press eBooks · doi:10.1093/med/9780190466268.003.0020

Efeito da adição de n-acetilcisteína ao tratamento com clozapina na perfusão cerebral de pacientes com esquizofrenia refratária

Souza, R. M. (2019) · doi:10.11606/d.17.2019.tde-05082019-115728

Evaluating Glutathione Peroxidase Activity as a Marker of Cognitive Impairment in Coronary Artery Disease Patients

Ahmed, M. A. (2019) · TSpace (University of Toronto)

THE PROTECTIVE EFFECT OF THE RESVERATROL AND N-ACETYLCYSTEINE COMBINATION ON THE LOCOMOTOR HYPERACTIVITY INDUCED WITH MK-801

GÜNDOĞAR, A. A., & AKOSMAN, M. S. (2020) · Kocatepe Veterinary Journal · doi:10.30607/kvj.752445

The influence of N-Acetylcysteine on locomotor activity, brain oxidative damage, and demyelination in MK-801 model of schizophreniaPreprint

AKOSMAN, M. S., Türkmen, R., & Demirel, H. H. (2021) · Research Square · doi:10.21203/rs.3.rs-471055/v1

Current Awareness

(2002) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.575

N-Acetylcysteine

Amini, A., Masoumi-Moghaddam, S., & Morris, D. L. (2016) · Springer eBooks · doi:10.1007/978-3-319-28570-2_4

Acetylcysteine

Rakkar, M., & Hillier, K. (2007) · xPharm: The Comprehensive Pharmacology Reference · doi:10.1016/b978-008055232-3.61160-2

Chapter 37. Complementary and Integrative Psychiatry

Massoumi, L., Gerbarg, P. L., Muskin, P. R., & Naidoo, U. (2019) · American Psychiatric Association Publishing eBooks · doi:10.1176/appi.books.9781615372980.lr37

Parkinson Disease

Simmons, A. D. (2012) · Elsevier eBooks · doi:10.1016/b978-1-4377-1793-8.00013-3

The Protective Effect of N-Acetylcysteine on MK-801 Induced Neurodegeneration in MicePreprint

AKOSMAN, M. S., Türkmen, R., & Demirel, H. H. (2022) · Research Square · doi:10.21203/rs.3.rs-1553614/v1

MRI Detection of Hepatic N-Acetylcysteine Uptake in Mice

Chen, J., Hwang, D. W., Chen, Y., Chen, T.-C., Yadav, N. N., Stait‐Gardner, T., Price, W. S., & Zheng, G. F. (2022) · Biomedicines · doi:10.3390/biomedicines10092138

PHARMACOLOGICAL APPLICATIONS AND PHARMACOKINETIC MODIFICATIONS OF N-ACETYLCYSTEINE

Joshy, A., Thomas, A., Baby, E., Biju, S. T., Mishra, B., & Jose, N. (2023) · International Journal of Pharmaceutics and Drug Analysis · doi:10.47957/ijpda.v11i1.535

The effect of NAC and Carnosine on alzheimer’s disease-related in vitro model through RAGE-AGE signaling pathway

Sirirattanakul, S. (2018) · doi:10.58837/chula.the.2018.141

UBQLN1 functions in telomere maintenance and differentiation of human embryonic stem cellsPreprint

Zhao, S., Li, J., Duan, S., Liu, C., Wang, H., Lu, J., Zhao, N., Sheng, X., Wu, Y., Li, Y., et al. (2024) · Research Square · doi:10.21203/rs.3.rs-3877910/v1

Additional file 1 of UBQLN1 links proteostasis and mitochondria function to telomere maintenance in human embryonic stem cells

Zhao, S., Li, J., Duan, S., Liu, C., Wang, H., Lu, J., Zhao, N., Sheng, X., Wu, Y., Li, Y., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26074137

Frontal white matter hyperintensity burden predicts cognitive response to N-acetylcysteine and exercise in vascular mild cognitive impairment

Mah, E., Gallagher, D., Gao, F., Ramirez, J., Rabin, J. S., Survilla, K., Vieira, D., Chen, J. J., Kang, Y., Andreazza, A. C., et al. (2026) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2026.01.005

Efficacy and safety of N-acetylcysteine in patients with mild cognitive impairment undergoing exercise-based cardiac rehabilitation program: a randomized controlled trial

Gallagher, D., Kang, Y., Herrmann, N., Kiss, A., Black, S. E., Oh, P., Marzolini, S., Rabin, J. S., Andreazza, A. C., Ramirez, J., et al. (2026) · Alzheimer s Research & Therapy · doi:10.1186/s13195-026-02062-z

Bypassing the bottleneck: Gamma-glutamylcysteine supplementation for brain glutathione enrichment in Alzheimer's disease

Mandal, P. K., Perry, G. L., Maroon, J. C., Corby, P., Patira, R., & López, O. L. (2026) · Journal of Alzheimer s Disease · doi:10.1177/13872877261474009

Effectiveness of N-acetylcysteine antioxidant administration in acute ischemic stroke on improving serum biomarkers of cognitive function

SUYONO, J. P., Warouw, F., Tangkudung, G., Wariki, W. M. V., Tumboimbela, M. J., & Pertiwi, J. M. (2026) · Gazzetta Medica Italiana Archivio per le Scienze Mediche · doi:10.23736/s0393-3660.25.06095-4

Neurodegenerative Processes as a Result of Infectious Agent Exposure and the Potential for Therapeutic Development

Lyagin, I. (2026) · Moscow University Chemistry Bulletin · doi:10.3103/s0027131426700276

Mitigating Oxidative Stress in Childhood Cerebral Adrenoleukodystrophy -An Investigation of N-acetylcysteine Pharmacology

Zhou, J. (2014) · University of Minnesota Digital Conservancy (University of Minnesota)

Effects of N-Acetyl-Cysteine on Neurocognition in a double-blind randomized placebo-controlled trial

Seidman, L. J., Conus, P., Fournier, M., Cleusix, M., Xin, L., Bauman, P., Ferrari, C., Cousins, A., Alameda, L., Gholam‐Rezaee, M., et al. (2016) · Infoscience (Ecole Polytechnique Fédérale de Lausanne)

Clinical trials of N-acetylcysteine in psychiatry and neurology: A systematic review.

(13684546), D., (13376715), J. S., (9884567), N. K., (13684549), L. D., Berk, M., (13088112), O. D., (13684552), C. S., & (13684555), R. F. (2025) · Figshare · Cited by 2

Overview on the Effects of N-Acetylcysteine in Neurodegenerative Diseases

Tardiolo, G., Bramanti, P., & Mazzon, E. (2018) · Molecules · doi:10.3390/molecules23123305 · Cited by 299

The effect of N-acetylcysteine (NAC) on human cognition – A systematic review

Skvarc, D., Dean, O. M., Byrne, L. K., Gray, L. J., Lane, S. E., Lewis, M., Fernandes, B. S., Berk, M., & Marriott, A. (2017) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2017.04.013 · Cited by 111

N-acetylcysteine treatment attenuates the cognitive impairment and synaptic plasticity loss induced by streptozotocin

Costa, M. D., Bernardi, J., Costa, L., Fiuza, T. D. L., Brandão, R., Ribeiro, M. F., Amaral, J. D., Rodrigues, C. M. P., & Pereira, M. E. (2017) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2017.05.008 · Cited by 23